Soft chewy confection comprising hmo
US-2024000098-A1 · Jan 4, 2024 · US
US11252986B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11252986-B2 |
| Application number | US-201315100407-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 29, 2013 |
| Priority date | Nov 29, 2013 |
| Publication date | Feb 22, 2022 |
| Grant date | Feb 22, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to the use of a nutritional composition having a low amount of protein, such as less than 1.8 g/100 kcal for administration to infants of non-obese and non-overweight mothers so as to reduce the risk of developing metabolic syndrome, increased weight gain, increased fat deposition, overweight, obesity, insulin resistance, glucose intolerance or diabetes mellitus later in said infant's life.
Opening claim text (preview).
The invention claimed is: 1. A method for reducing the risk of developing a disorder selected from the group consisting of metabolic syndrome, increased weight gain, increased fat deposition, overweight, obesity, insulin resistance, glucose intolerance, diabetes mellitus, and combinations thereof later in an infant's life, the method comprising administering a nutritional composition comprising a protein source, a lipid source, and a carbohydrate source to the infant in the first year of life of the infant, wherein the nutritional composition comprises 1.4 to 1.7 g of the protein source/100 kcal of the nutritional composition and has an energy density from 600 to 680 kcal/litre, the protein source comprises sweet whey from which a caseino-glycomacropeptide has been removed, the nutritional composition additionally includes free phenylalanine in an amount of up to 2.2%, free isoleucine in an amount of up to 0.92%, free tryptophan in an amount of up to 0.34% and free histidine in an amount of up to 0.19% by weight of a total protein content, and the infant was born to a non-obese and non-overweight mother. 2. The method according to claim 1 , wherein the energy density of the nutritional composition is from 620 to 650 kcal/litre. 3. The method according to claim 1 , wherein the energy density of the nutritional composition is from 650 to 680 kcal/litre. 4. The method according to claim 1 , wherein the protein source includes casein and/or whey protein. 5. The method according to claim 1 , wherein the protein source includes casein. 6. The method according to claim 1 , wherein the protein source has a casein to whey ratio from 30:70 to 70:30. 7. The method according to claim 1 , wherein the protein source is fully or partially hydrolysed. 8. The method according to claim 1 , wherein the protein source is intact. 9. The method according to claim 1 , wherein the nutritional composition includes a probiotic strain in an amount of from 10 6 to 10 11 cfu/g dry weight of the nutritional composition. 10. The method according to claim 1 , wherein the energy density of the nutritional composition is about 670 kcal/litre.
Amino acids, peptides or proteins · CPC title
Dairy proteins · CPC title
Anorexiants; Antiobesity agents · CPC title
Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.